77 related articles for article (PubMed ID: 23167816)
1. Chip-based nanostructured sensors enable accurate identification and classification of circulating tumor cells in prostate cancer patient blood samples.
Ivanov I; Stojcic J; Stanimirovic A; Sargent E; Nam RK; Kelley SO
Anal Chem; 2013 Jan; 85(1):398-403. PubMed ID: 23167816
[TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive electrochemical biomolecular detection using nanostructured microelectrodes.
Sage AT; Besant JD; Lam B; Sargent EH; Kelley SO
Acc Chem Res; 2014 Aug; 47(8):2417-25. PubMed ID: 24961296
[TBL] [Abstract][Full Text] [Related]
3. Sample-to-Answer Isolation and mRNA Profiling of Circulating Tumor Cells.
Mohamadi RM; Ivanov I; Stojcic J; Nam RK; Sargent EH; Kelley SO
Anal Chem; 2015 Jun; 87(12):6258-64. PubMed ID: 26009151
[TBL] [Abstract][Full Text] [Related]
4. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
[TBL] [Abstract][Full Text] [Related]
6. Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit.
Fang Z; Soleymani L; Pampalakis G; Yoshimoto M; Squire JA; Sargent EH; Kelley SO
ACS Nano; 2009 Oct; 3(10):3207-13. PubMed ID: 19736919
[TBL] [Abstract][Full Text] [Related]
7. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
8. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
10. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
11. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
12. Optimized templates for bottom-up growth of high-performance integrated biomolecular detectors.
Lam B; Holmes RD; Das J; Poudineh M; Sage A; Sargent EH; Kelley SO
Lab Chip; 2013 Jul; 13(13):2569-75. PubMed ID: 23455732
[TBL] [Abstract][Full Text] [Related]
13. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
14. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization.
Li X; Wong C; Mysel R; Slobodov G; Metwalli A; Kruska J; Manatt CS; Culkin DJ; Kropp BP; Lin HK
Mol Cancer; 2005 Aug; 4(1):30. PubMed ID: 16086835
[TBL] [Abstract][Full Text] [Related]
16. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
19. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
20. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
